Bertolotti M, Maurantonio M, Gabbi C, Anzivino C, Carulli N. Hyperlipidaemia and cardiovascular risk. Aliment Pharmacol Ther. 2005;22:28–30.

Article  PubMed  Google Scholar 

Dominiczak MH. Hyperlipidaemia and cardiovascular disease-back to basics: dietary patterns, foods and cardiovascular risk. Curr Opin Lipidol. 2011;22(6):509–11.

Article  CAS  PubMed  Google Scholar 

Meguro S, Ishibashi M, Takei I. The significance of high sensitive C reactive protein as a risk factor for cardiovascular diseases. Rinsho Byori Japanese J Clin Pathol. 2012;60(4):356–61.

CAS  Google Scholar 

Koenig W. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Int J Cardiol. 2013;168(6):5126–34.

Article  PubMed  Google Scholar 

Backes JM, Howard PA, Moriarty PM. Role of C-reactive protein in cardiovascular disease. Ann Pharmacother. 2004;38(1):110–8.

Article  CAS  PubMed  Google Scholar 

Habib SS, Al Masri AA. Relationship of high sensitivity C-reactive protein with presence and severity of coronary artery disease. Pakistan J Med Sci. 2013;29(6):1425.

Google Scholar 

Ridker PM. Risk factors for atherosclerotic disease. Heart disease. 2001.

Koenig W, Sund M, Fröhlich M, Fischer H-G, Löwel H, Döring A, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring trends and determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999;99(2):237–42.

Article  CAS  PubMed  Google Scholar 

Asgary S, Kelishadi R, Rafieian-Kopaei M, Najafi S, Najafi M, Sahebkar A. Investigation of the lipid-modifying and antiinflammatory effects of cornus mas L. supplementation on dyslipidemic children and adolescents. Pediatr Cardiol. 2013;34(7):1729–35.

Article  PubMed  Google Scholar 

Asgary S, Rafieian-Kopaei M, Shamsi F, Najafi S, Sahebkar A. Biochemical and histopathological study of the anti-hyperglycemic and anti-hyperlipidemic effects of cornelian cherry (Cornus mas L.) in alloxan-induced diabetic rats. J Complement Integr Med. 2014;11(2):63–9.

Article  PubMed  Google Scholar 

Iranshahi M, Askari M, Sahebkar A, Hadjipavlou-Litina D. Evaluation of antioxidant, anti-inflammatory and lipoxygenase inhibitory activities of the prenylated coumarin umbelliprenin. Daru. 2009;17(2):99–103.

CAS  Google Scholar 

Johnston TP, Korolenko TA, Pirro M, Sahebkar A. Preventing cardiovascular heart disease: promising nutraceutical and non-nutraceutical treatments for cholesterol management. Pharmacol Res. 2017;120:219–25.

Article  CAS  PubMed  Google Scholar 

Momtazi AA, Banach M, Pirro M, Katsiki N, Sahebkar A. Regulation of PCSK9 by nutraceuticals. Pharmacol Res. 2017;120:157–69.

Article  CAS  PubMed  Google Scholar 

Parsamanesh N, Asghari A, Sardari S, Tasbandi A, Jamialahmadi T, Xu S et al. Resveratrol and endothelial function: a literature review. Pharmacol Res. 2021;170.

Sahebkar A, Ferri C, Giorgini P, Bo S, Nachtigal P, Grassi D. Effects of pomegranate juice on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2017;115:149–61.

Article  CAS  PubMed  Google Scholar 

Sahebkar A, Serban MC, Gluba-Brzózka A, Mikhailidis DP, Cicero AF, Rysz J, et al. Lipid-modifying effects of nutraceuticals: an evidence-based approach. Nutrition. 2016;32(11–12):1179–92.

Article  CAS  PubMed  Google Scholar 

Serban C, Sahebkar A, Ursoniu S, Andrica F, Banach M. Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2015;33(6):1119–27.

Article  CAS  PubMed  Google Scholar 

Pagliaro B, Santolamazza C, Simonelli F, Rubattu S. Phytochemical compounds and Protection from Cardiovascular diseases: a state of the art. Biomed Res Int. 2015;2015:918069.

Article  PubMed  PubMed Central  Google Scholar 

Jones PJ, AbuMweis SS. Phytosterols as functional food ingredients: linkages to cardiovascular disease and cancer. Curr Opin Clin Nutr Metabolic Care. 2009;12(2):147–51.

Article  CAS  PubMed  Google Scholar 

Baumgartner S, Mensink P, Plat R. Plant sterols and stanols in the treatment of dyslipidemia: new insights into targets and mechanisms related to cardiovascular risk. Curr Pharm Design. 2011;17(9):922–32.

Article  CAS  Google Scholar 

Ostlund RE Jr. Phytosterols in human nutrition. Annu Rev Nutr. 2002;22(1):533–49.

Article  CAS  PubMed  Google Scholar 

Ostlund RE Jr, McGill JB, Zeng C-M, Covey DF, Stearns J, Stenson WF, et al. Gastrointestinal absorption and plasma kinetics of soy ∆5-phytosterols and phytostanols in humans. Am J Physiology-Endocrinology Metabolism. 2002;282(4):E911–6.

Article  CAS  PubMed  Google Scholar 

Investigators MIGC. Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med. 2014;371(22):2072–82.

Article  Google Scholar 

Sudhop TM. Sitosterolemia—a rare disease. Clin Res Cardiol. 2004;93(12):921–8.

CAS  Google Scholar 

Athyros VG, Kakafika AI, Papageorgiou AA, Tziomalos K, Peletidou A, Vosikis C, et al. Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors. Nutr Metabolism Cardiovasc Dis. 2011;21(3):213–21.

Article  CAS  PubMed  Google Scholar 

Devaraj S, Autret BC, Jialal I. Reduced-calorie orange juice beverage with plant sterols lowers C-reactive protein concentrations and improves the lipid profile in human volunteers. Am J Clin Nutr. 2006;84(4):756–61.

Article  CAS  PubMed  Google Scholar 

Micallef MA, Garg ML. Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis. 2009;204(2):476–82.

Article  CAS  PubMed  Google Scholar 

Cater NB, Garcia-Garcia A-B, Vega GL, Grundy SM. Responsiveness of plasma lipids and lipoproteins to plant stanol esters. Am J Cardiol. 2005;96(1):23–8.

Article  Google Scholar 

De Jong A, Plat J, Bast A, Godschalk R, Basu S, Mensink R. Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment. Eur J Clin Nutr. 2008;62(2):263–73.

Article  PubMed  Google Scholar 

Gagliardi ACM, Maranhão RC, De Sousa H, Schaefer EJ, Santos R. Effects of margarines and butter consumption on lipid profiles, inflammation markers and lipid transfer to HDL particles in free-living subjects with the metabolic syndrome. Eur J Clin Nutr. 2010;64(10):1141–9.

Article  CAS  PubMed  Google Scholar 

Hansel B, Nicolle C, Lalanne F, Tondu F, Lassel T, Donazzolo Y, et al. Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemia. Am J Clin Nutr. 2007;86(3):790–6.

Article  CAS  PubMed  Google Scholar 

Hernández-Mijares A, Bañuls C, Jover A, Solá E, Bellod L, Martínez-Triguero ML, et al. Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic syndrome. Clin Nutr. 2011;30(5):604–9.

Article  PubMed  Google Scholar 

Hongu N, Kitts DD, Zawistowski J, Dossett CM, Kopeć A, Pope BT, et al. Pigmented Rice Bran and Plant sterol combination reduces serum lipids in overweight and obese adults. J Am Coll Nutr. 2014;33(3):231–8.

Article  PubMed  PubMed Central  Google Scholar 

Plat J, Brufau G, Dallinga-Thie GM, Dasselaar M, Mensink RP. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J Nutr. 2009;139(6):1143–9.

Article  CAS  PubMed  Google Scholar 

Sialvera T, Pounis G, Koutelidakis A, Richter D, Yfanti G, Kapsokefalou M, et al. Phytosterols supplementation decreases plasma small and dense LDL levels in metabolic syndrome patients on a westernized type diet. Nutr Metabolism Cardiovasc Dis. 2012;22(10):843–8.

Article  CAS